← Eichor
Study identifier: NCT07595432 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Technique and Its Effect on Visual Performance.

Condition: Visual Outcome  ·  Sponsor: Hoya Surgical Optics, Inc.

PhaseN/A
Planned participants140
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, multicenter, parallel groups, non-interventional, examiner masked, comparative clinical study. Patients that participated in previous Hoya studies, and patients previous implanted with Hoya non-toric monofocal IOLs (sub-study only) will be enrolled in the study. The sample size for this study is based on demonstrating the non-inferiority of the mean distance-corrected intermediate visual acuity (DCIVA) in Group 1 (Site 1) compared with Group 2 (Site 2).

This description comes directly from the study's public registry record.

Talk to the study team

Srividhya Medical Monitor  ·  +1-909-680-3900  ·  srividhya.vilupuru@hoya.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peregrine Eye Laser InstituteManila, PhilippinesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07595432